John Nicolette

1.3k total citations
20 papers, 469 citations indexed

About

John Nicolette is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, John Nicolette has authored 20 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 9 papers in Molecular Biology and 9 papers in Health, Toxicology and Mutagenesis. Recurrent topics in John Nicolette's work include Carcinogens and Genotoxicity Assessment (14 papers), Effects and risks of endocrine disrupting chemicals (7 papers) and DNA Repair Mechanisms (6 papers). John Nicolette is often cited by papers focused on Carcinogens and Genotoxicity Assessment (14 papers), Effects and risks of endocrine disrupting chemicals (7 papers) and DNA Repair Mechanisms (6 papers). John Nicolette collaborates with scholars based in United States, United Kingdom and Switzerland. John Nicolette's co-authors include Krista L. Dobo, Susanne Glowienke, Laura Custer, Anthony Lynch, Joel P. Bercu, Véronique Thybaud, Svetlana L. Avlasevich, Michelle Kenyon, Stephen D. Dertinger and Steven M. Bryce and has published in prestigious journals such as Chemical Research in Toxicology, Mutation Research/Reviews in Mutation Research and Regulatory Toxicology and Pharmacology.

In The Last Decade

John Nicolette

20 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Nicolette United States 10 209 152 130 92 52 20 469
Angela White United Kingdom 10 180 0.9× 100 0.7× 97 0.7× 131 1.4× 49 0.9× 22 427
Jacky Van Gompel Belgium 12 267 1.3× 216 1.4× 142 1.1× 106 1.2× 100 1.9× 18 668
Esther Vock Germany 9 151 0.7× 131 0.9× 81 0.6× 58 0.6× 38 0.7× 16 337
Laura Custer United States 16 306 1.5× 213 1.4× 164 1.3× 175 1.9× 101 1.9× 22 673
Susanne Glowienke Switzerland 16 237 1.1× 136 0.9× 172 1.3× 221 2.4× 59 1.1× 28 700
S. A. Stalford United Kingdom 10 64 0.3× 168 1.1× 98 0.8× 68 0.7× 40 0.8× 14 393
Gilles Klopman United States 12 196 0.9× 134 0.9× 120 0.9× 212 2.3× 49 0.9× 19 533
Wera Teubner Germany 14 126 0.6× 279 1.8× 116 0.9× 68 0.7× 105 2.0× 23 999
Zhanna Sobol United States 11 98 0.5× 165 1.1× 77 0.6× 28 0.3× 26 0.5× 17 425
Elena Fioravanzo Italy 11 44 0.2× 136 0.9× 82 0.6× 106 1.2× 45 0.9× 31 436

Countries citing papers authored by John Nicolette

Since Specialization
Citations

This map shows the geographic impact of John Nicolette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Nicolette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Nicolette more than expected).

Fields of papers citing papers by John Nicolette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Nicolette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Nicolette. The network helps show where John Nicolette may publish in the future.

Co-authorship network of co-authors of John Nicolette

This figure shows the co-authorship network connecting the top 25 collaborators of John Nicolette. A scholar is included among the top collaborators of John Nicolette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Nicolette. John Nicolette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trejo‐Martin, Alejandra, Joel P. Bercu, Rachael E. Tennant, et al.. (2022). Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines. Regulatory Toxicology and Pharmacology. 135. 105247–105247. 31 indexed citations
2.
Graham, Jessica, Alejandra Trejo‐Martin, Jakub Kostal, et al.. (2022). An Evaluation of the Occupational Health Hazards of Peptide Couplers. Chemical Research in Toxicology. 35(6). 1011–1022. 35 indexed citations
3.
Crosby, Meredith E., et al.. (2022). Exploring the molecular and functional cellular response to hydrazine via transcriptomics and DNA repair mutant cell lines. Environmental and Molecular Mutagenesis. 63(7). 336–350. 3 indexed citations
4.
Graham, Jessica, Mark W. Powley, Susanne Glowienke, et al.. (2021). Calculating qualified non-mutagenic impurity levels: Harmonization of approaches. Regulatory Toxicology and Pharmacology. 126. 105023–105023. 7 indexed citations
5.
Bauer, Daniel, Lorrene A. Buckley, Heidrun Ellinger‐Ziegelbauer, et al.. (2021). A cross-industry survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10. Regulatory Toxicology and Pharmacology. 125. 105017–105017. 4 indexed citations
6.
Hutchinson, Richard W., et al.. (2021). Harmonized 3Rs-based non-mutagenic impurity qualification study designs developed using the results of an IQ consortium survey. Regulatory Toxicology and Pharmacology. 122. 104895–104895. 7 indexed citations
7.
Nicolette, John, Mirjam Luijten, Jennifer C. Sasaki, et al.. (2021). Utility of a next‐generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide. Environmental and Molecular Mutagenesis. 62(9). 512–525. 5 indexed citations
8.
9.
Johnson, George E., Krista L. Dobo, B. Bhaskar Gollapudi, et al.. (2021). Permitted daily exposure limits for noteworthy N‐nitrosamines. Environmental and Molecular Mutagenesis. 62(5). 293–305. 52 indexed citations
10.
Hasselgren, Catrin, Joel P. Bercu, Kevin P. Cross, et al.. (2020). Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updates. Regulatory Toxicology and Pharmacology. 118. 104807–104807. 26 indexed citations
11.
Nicolette, John, et al.. (2020). In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine. Environmental and Molecular Mutagenesis. 62(1). 4–17. 5 indexed citations
12.
Bercu, Joel P., Sheila M. Galloway, Andrew Teasdale, et al.. (2018). Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromides. Regulatory Toxicology and Pharmacology. 94. 172–182. 36 indexed citations
13.
Nicolette, John, Kamala Pant, Meredith E. Crosby, et al.. (2018). A comparison of 24 chemicals in the six-well bacterial reverse mutation assay to the standard 100-mm Petri plate bacterial reverse mutation assay in two laboratories. Regulatory Toxicology and Pharmacology. 100. 134–160. 3 indexed citations
14.
Nicolette, John, et al.. (2017). A regenerative erythropoietic response does not increase the frequency of Pig‐a mutant reticulocytes and erythrocytes in Sprague‐Dawley rats. Environmental and Molecular Mutagenesis. 59(1). 91–95. 6 indexed citations
15.
Nicolette, John, et al.. (2016). Peptide bond‐forming reagents HOAt and HATU are not mutagenic in the bacterial reverse mutation test. Environmental and Molecular Mutagenesis. 57(3). 236–240. 4 indexed citations
16.
Sutter, Andreas, Alexander Amberg, Scott Boyer, et al.. (2013). Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology. 67(1). 39–52. 88 indexed citations
17.
Escobar, Patricia A., Raymond A. Kemper, John Nicolette, et al.. (2012). Bacterial mutagenicity screening in the pharmaceutical industry. Mutation Research/Reviews in Mutation Research. 752(2). 99–118. 49 indexed citations
18.
Nicolette, John, et al.. (2010). In vitro micronucleus screening of pharmaceutical candidates by flow cytometry in Chinese hamster V79 cells. Environmental and Molecular Mutagenesis. 52(5). 355–362. 13 indexed citations
19.
Avlasevich, Svetlana L., Steven M. Bryce, M. De Boeck, et al.. (2010). Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future. Mutagenesis. 26(1). 147–152. 46 indexed citations
20.
Bryce, Steven M., Jing Shi, John Nicolette, et al.. (2009). High content flow cytometric micronucleus scoring method is applicable to attachment cell lines. Environmental and Molecular Mutagenesis. 51(3). 260–266. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela White Breakdown of academic impact, for papers by Jacky Van Gompel Breakdown of academic impact, for papers by Esther Vock Breakdown of academic impact, for papers by Laura Custer Breakdown of academic impact, for papers by Susanne Glowienke Breakdown of academic impact, for papers by S. A. Stalford Breakdown of academic impact, for papers by Gilles Klopman Breakdown of academic impact, for papers by Wera Teubner Breakdown of academic impact, for papers by Zhanna Sobol Breakdown of academic impact, for papers by Elena Fioravanzo
Rankless by CCL
2026